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involution is the process of post-lactational mammary gland regression to quiescence and it involves secretory epithelial 
cell death, stroma remodeling and gland repopulation by adipocytes. Though reportedly accompanying apoptosis, the 
role of autophagy in involution has not yet been determined. We now report that autophagy-related (ATG) proteins 
mediate dead cell clearance and suppress inflammation during mammary involution. in vivo, Becn1+/− and Atg7-deficient 
mammary epithelial cells (Mecs) produced ‘competent’ apoptotic bodies, but were defective phagocytes in association 
with reduced expression of the MeRTK and iTGB5 receptors, thus pointing to defective apoptotic body engulfment. 
Atg-deficient tissues exhibited higher levels of involution-associated inflammation, which could be indicative of a 
tumor-modulating microenvironment, and developed ductal ectasia, a manifestation of deregulated post-involution 
gland remodeling. in vitro, ATG (BecN1 or ATG7) knockdown compromised Mec-mediated apoptotic body clearance 
in association with decreased RAc1 activation, thus confirming that, in addition to the defective phagocytic processing 
reported by other studies, ATG protein defects also impair dead cell engulfment.
Using two different mouse models with mammary gland-associated Atg deficiencies, our studies shed light to the 
essential role of ATG proteins in Mec-mediated efferocytosis during mammary involution and provide novel insights 
into this important developmental process. This work also raises the possibility that a regulatory feedback loop exists, by 
which the efficacy of phagocytic cargo processing in turn regulates the rate of engulfment and ultimately determines the 
kinetics of phagocytosis and dead cell clearance.
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mechanism in response to apoptosis-inducing signals triggered 
by cessation of lactation,26 autophagy defects may accelerate 
MEC apoptosis and gland remodeling; alternatively, autophagy 
may act as a cell death mechanism complementary to apoptosis22 
and, thus, its impairment may decrease MEC death and delay 
involution; the autophagic machinery may also participate in 
dead cell removal.27 To date, there is no genetic evidence sup-
porting a particular functional role for autophagy in mammary 
involution over another.
Using the Gfp-Lc3 mice,28 ubiquitously expressing a fluores-
cent GFP-fusion of the essential autophagy-related (ATG) pro-
tein LC3 (ortholog of ATG8), we determined that autophagy 
is induced early in involution. Monoallelic Becn1 loss or MEC-
specific Atg7 deletion compromised autophagosome formation, 
but did not affect apoptosis during the first 48 h post-weaning; 
however, the second involution phase was prolonged in associa-
tion with delayed alveolar collapse, dead cell accumulation in 
alveolar lumens and slower gland repopulation by adipocytes. 
Atg-defective mammary tissues exhibited persistent involution-
associated macrophage infiltration, which possibly creates a 
tumor-modulating microenvironment, and developed ductal 
ectasia, that is indicative of long-term impairment in mammary 
remodeling. Our studies genetically confirm the critical role of 
MECs in dead cell clearance during involution and expand the 
accumulating evidence on the importance of ATG proteins in 
phagocytosis,29 innate immune response30,31 and efferocytosis32,33 
by demonstrating that, in addition to the previously reported 
endocytic processing defect,29,32,34 impairment of autophagic 
machinery proteins compromises efferocytosis in vivo at the early 
step of engulfment.
Results
Atg-dependent autophagy induction in early mammary involu-
tion. The functional status of autophagy at different stages of 
mammary gland development was investigated in the Gfp-Lc3 
mice,28 ubiquitously expressing the ATG protein LC3 (ATG8) 
fused to GFP (Fig. 1A). The diffuse cytoplasmic LC3 distribu-
tion observed in virgin and lactating mammary glands changed 
to a perinuαclear punctate pattern, indicative of LC3 lipidation 
and translocation to the autophagosome membrane, within hours 
of forced pup-weaning, demonstrating autophagy induction very 
early in involution. Autophagosome formation peaked at 24 h 
post-weaning and returned to baseline after 72 h. Mammary 
gland Becn1 mRNA was induced during lactation and peaked 
at 24 h post-weaning, whereas Atg7 and Map1lc3α (Lc3) mRNA 
levels were induced only during involution (Fig. 1B).
Allelic Becn1 loss or MEC-specific Atg7 deletion compromised 
involution-induced autophagy (Fig. 2A and B, and Fig. 2D–F, 
respectively) and was accompanied by severely blunted changes 
in Becn1 and Lc3 mRNA (Fig. 2C and G), thus indicating that 
upregulation of autophagy in the early phase of mammary invo-
lution is both Becn1- and Atg7-dependent, and defects in either 
ATG protein decrease postlactational autophagy induction. In 
contrast to the ubiquitous (in all cell types and tissues) monoallelic 
Becn1 deletion in Becn1+/− mice, in the mammary gland-specific 
Background
During development, the mammary gland undergoes well-
orchestrated, hormone-dependent morphological changes to 
become a milk-producing machine during pregnancy and lacta-
tion, which subsequently regresses to a quiescent organ by invo-
lution.1,2 In early gestation, mammary epithelial cells (MECs) 
proliferate, whereas in late pregnancy and lactation, they dif-
ferentiate for milk production. During involution, most secre-
tory alveolar MECs undergo programmed cell death (PCD); 
remaining cells are remodeled into pre-pregnancy-like glandular 
structures, in a process consisting of two phases and completed 
within 10 d in mice.3 The first involution phase, lasting 48 h 
post-weaning, is regulated by local factors4,5 and is reversible, 
i.e., if pups are returned to mother, MEC death is halted and 
lactation resumes; the second phase is regulated by circulating 
hormones,3 is characterized by extensive tissue remodeling that 
is dependent on matrix metalloproteinases (MMPs),6 and is 
irreversible.
Within the first 72 h, residual milk and dead cells are primar-
ily cleared from alveolar lumens by neighboring, living MECs in 
a highly conserved process resembling phagocytosis and uniquely 
termed efferocytosis (from the greek word ‘effero’, to carry to the 
grave).7,8 Professional phagocytes, such as macrophages, also 
infiltrate the gland, mostly after the third day of involution,8 and 
play a critical role in stroma remodeling,9 concomitantly creat-
ing a tumor-promoting microenvironment10,11 that potentially 
contributes to the poor prognosis of pregnancy-associated breast 
cancer (PABC).12
Leukemia inhibitory factor (LIF),13,14 death receptor 
ligands10,15 and transforming growth factor β 3 (TGFB3)16 are 
strongly upregulated during the first 12 h of involution, and 
the Janus kinase (JAK)-signal transducer and activator of tran-
scription (STAT) pathway, induced by LIF-dependent STAT3 
phosphorylation, is critical for apoptosis initiation and timely 
gland involution.13,14,17,18 CD14 is also upregulated during involu-
tion and exposed on MECs in a STAT3-dependent manner.10,19 
Although PCD during mammary involution has been primarily 
attributed to apoptosis, a recent study showed that cell death dur-
ing the first phase of involution is mediated by permeabilization 
of lysosomal membranes.20 It is, thus, important to note that the 
term “apoptosis” as used here also includes this newly described 
lysosome-mediated cell death.
Studies on bovine mammary glands have demonstrated that, 
in parallel to apoptosis, the self-catabolic process of autophagy21 
is also activated during involution.22,23 In vitro, apoptosis and 
autophagy induction in bovine MECs is accompanied by TGFB1 
and TGFBR2 upregulation,23 resulting in increased insulin 
growth factor-binding protein (IGFBP) levels and decreased 
AKT phosphorylation.24 Autophagy regulation in MECs is even 
more complex, as EGF also suppresses autophagy via MTOR 
activation, whereas 17β-estradiol and progesterone stimulate 
autophagy by suppressing MTOR.25
Despite evidence for autophagy induction during involu-
tion, its specific role during this important developmental pro-
cess remains unclear. If autophagy is activated as a cell-survival 
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Figure 1. Autophagy is induced in the early phase of mammary involution. (A) GFP fluorescence on frozen sections of mammary glands from GFP-LC3 
mice. (B) RT-PcR quantification of Becn1, Atg7 and Map1lc3α mRNA in mammary glands from wild-type mice. L (Lact), lactation; i (inv), involution;  
d, days; h, hours.
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Atg7 deletion compromised involution-associated LC3 upregula-
tion, thus suggesting that LC3 induction is dependent on and/or 
coregulated with BECN1 and ATG7 expression. To our knowl-
edge, this finding has not been reported before and is definitely 
worthy of further investigation.
Atg7-deficient mouse model described here, Atg7 was deleted only 
in secretory MECs after pregnancy and lactation,35,36 thus indi-
cating that alveolar epithelial cells are primarily responsible for 
the autophagic response observed shortly after pup weaning. It 
is also of interest that both allelic Becn1 loss and MEC-specific 
Figure 2. Monoallelic Becn1 loss or Mec-specific Atg7 deletion compromises autophagy induction in mammary involution. (A) eM micrographs of 
Becn1+/+ and Becn1+/− mammary glands on day 2 post-weaning. Red arrows point to autophagosomes. (B) Quantification of autophagosomes in Becn1+/+ 
and Becn1+/− mammary glands on day 2 post-weaning by eM. (C) RT-PcR quantification of Becn1 and Map1lc3α mRNA in mammary glands from Becn1+/− 
mice. (D–F) ATG7, Lc3 and sQsTM1 ihc respectively on mammary glands from parous wild-type and Atg7F/F;WAP-Cre mice on day 2 post-weaning.  
(G) RT-PcR quantification of Becn1 and Map1lc3α mRNA in mammary glands from parous wild-type and Atg7F/F;WAP-Cre mice type. L, lactation; i, invo-
lution; d, days; h, hours. Parous mice: after second pregnancy and lactation.
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increased between 48 and 96 h, remaining high at least until 
involution day 5 and probably accounting for the persistently 
high AB numbers in Becn1+/− and MEC-specific Atg7-deficient 
mammary glands beyond 72 h; abnormal intraluminal dead cell 
accumulation (Fig. 5G) and milk retention (Fig. 3) were in turn 
the most likely reasons behind delayed alveolar collapse in Atg-
deficient mammary glands (Fig. 3).
Atg defects delay mammary invo-
lution in association with dead cell 
accumulation in alveolar lumens. To 
investigate how Atg defects impact 
mammary involution, we examined 
wild-type, Becn1+/− and MEC-specific 
Atg7-deficient mammary glands at 
successive involution time points 
(Figs. 3 and 4). Transient involution 
delays, most apparent between days 
3 and 5 post-weaning, were observed 
in both Atg-deficient genetic back-
grounds. Involuting gland morphol-
ogy appeared grossly unaffected by 
autophagy functional status within 
the first 48 h. However, Becn1+/− and 
MEC-specific Atg7-deficient mam-
mary glands demonstrated abnor-
mally distended milk- and dead 
cell-filled alveoli for at least 72 and 
96 h post-weaning, respectively 
(Fig. 3) and an accompanying delay in 
stroma remodeling (Fig. 4). Becn1+/− 
and MEC-specific Atg7-deficient 
glands were repopulated by adipo-
cytes to wild-type levels after 5 and 
10 d, respectively (Fig. 4), indicating 
that MEC-specific Atg7 deficiency 
resulted in longer, though still tem-
porary, gland remodeling delay than 
ubiquitous monoallelic Becn1 loss.
To gain insight into the 
mechanism(s) by which defects in 
autophagic machinery proteins delay 
involution, MEC apoptosis was 
quantified (Fig. 5A, B, D and E). 
During the first 72 h post-weaning, 
MECs exhibited high apoptotic 
rates, independent of autophagic 
responsiveness (Fig. 5B and E). 
Although autophagy is regularly 
induced as a cytoprotective mecha-
nism under stress,37-40 the observa-
tion that autophagy-defective MECs 
were not more susceptible than their 
wild-type counterparts to post-lacta-
tional cell death was not surprising, 
given that the prosurvival effects of 
autophagy become readily apparent 
only in an apoptosis-defective background.37-40 Quantification 
of apoptotic body (AB) clearance by neighboring, still living, 
MECs revealed that Atg-deficient MECs exhibited decreased 
engulfment compared with wild-type MECs after the first 
24 h post-weaning, i.e., after the peak of autophagosome for-
mation (Fig. 5C and F). Furthermore, engulfment differ-
ence between wild-type and Atg-deficient MECs continually 
Figure 3. Monoallelic Becn1 loss or Mec-specific Atg7 deletion delays mammary involution. h&e-
stained sections of formalin-fixed and paraffin-embedded mammary tissues from parous wild-type, 
Becn1+/− and Atg7F/F;WAP-Cre mice on days 1–7 post-weaning. Parous mice: after second pregnancy and 
lactation.
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Figure 4. Monoallelic Becn1 loss or Mec-specific Atg7 deletion delays mammary involution. (A) Whole mammary gland mounts from parous wild-type, 
Becn1+/− and Atg7F/F;WAP-Cre mice on days 1–4 post-weaning. (B) Mammary gland repopulation by adipocytes (adipose tissue/total mammary tissue, 
%) during days 0.5–14 post-weaning.
Figure 5 (See opposite page). involution delay in Atg-deficient mammary glands is associated with dead cell accumulation in alveolar lumens.  
(A) cleaved cAsP3 ihc on mammary glands from wild-type and Becn1+/− mice on involution days 1 and 4. (B) Quantification of post-lactational 
apoptotic bodies in mammary glands from wild-type and Becn1+/− mice during involution days 0.5–21. (C) Fraction of apoptotic bodies engulfed by 
living Mecs in mammary glands from wild-type (blue line) and Becn1+/− (red line) mice during involution days 1–5. (D) cleaved cAsP3 ihc on mammary 
glands from wild-type and Mec-specific Atg7-deficient mice on involution days 1 and 4. (E) Quantification of post-lactational apoptotic bodies in mam-
mary glands from wild-type and Mec-specific Atg7-deficient mice during involution days 0.5–21. (F) Fraction of apoptotic bodies engulfed by living 
Mecs in mammary glands from wild-type (green line) and Mec-specific Atg7-deficient (yellow line) mice during involution days 1–5. (G) Apoptotic 
body distribution between non-engulfed (i.e., in alveolar lumens, L) and engulfed (i.e., inside Mecs in alveolar wall, W) fractions in mammary glands 
from wild-type (blue and green bars), Becn1+/− (red bars) and Mec-specific Atg7-deficient (yellow bars) mice during days 2–4 post-weaning. **p 0.001,  
*p 0.01.
www.landesbioscience.com Autophagy 465
Figure 5. For figure legend, see page 464.
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(Fig. 7C, right column). Atg-deficient mammary glands from 
older multiparous mice demonstrated prominent ductal ectasia 
(Fig. 7D), which—though not a preneoplastic condition itself—
is indicative of abnormal ductal remodeling in association with 
defective dead cell clearance during mammary involution.
ATG protein knockdown compromises iMMEC phagocytic 
ability in vitro in association with decreased apoptotic body 
engulfment and impaired Rac activation. To further investigate 
the mechanism(s) underlying the in vivo efferocytosis defect of 
Atg-defective MECs, we initially used iMMEC cell lines derived 
from Becn1+/+ and Becn1+/− mice.39 To our surprise, Becn1+/− 
iMMECs, which are partially defective in autophagy induction 
under metabolic stress,39 did not exhibit any significant phago-
cytosis impairment (Fig. 8A). This result, though unexpected, 
has a precedent in earlier work,46 where the PS exposure defect 
documented in Becn1- and Atg5-null ES cells in a 3D-model of 
embryoid body cavitation was not observed in single layer ES cell 
culture treated with apoptosis-inducing agents, thus indicating 
that in vivo properties of Atg-defective cells may be altered in 
regular 2D-culture.
In contrast, BECN1 or ATG7 knockdown (KD) by siRNA 
decreased the phagocytic index of wild-type iMMECs (Fig. 8B 
and C). Furthermore, similar to the in vivo results (Fig. 6B), 
BECN1 or ATG7 KD did not affect PS exposure on resultant 
ABs (Fig. 8D and E). Given decreased MERTK and ITGB5 
levels in Atg-defective mammary glands during involution in 
vivo (Fig. 7E) and, thus, predicted impairment of their down-
stream effector RAC1, which mediates actin reorganization and 
phagocytic cup formation for effective dead cell engulfment,47 we 
investigated whether BECN1 or ATG7 KD affected RAC1 acti-
vation during efferocytosis in vitro and found that in both cases 
RAC1 upregulation was significantly compromised (Fig. 8F), 
again indicating that impaired efferocytosis due to Atg defects 
can be attributed, at least partially, to defective engulfment.
Discussion
Using the Gfp-Lc3 autophagy-reporter mouse model,28 we found 
that autophagy is induced shortly after weaning and is accompa-
nied by transcriptional upregulation of ATG proteins. Our find-
ings are in agreement with earlier DNA microarray studies,10,48 
which included data on induction of ATG proteins and their 
regulators during early involution in parallel with downregula-
tion of autophagy suppressors, such as AKT and MTOR. MEC 
apoptosis is maximal and autophagy status-independent during 
the first 72 h post-weaning (Fig. 5B and E). In wild-type mam-
mary glands, apoptotic cell number drops acutely by involution 
day 4 and nears zero by day 5, suggesting that most dead cells 
are efficiently cleared between 72 and 96 h, i.e., after the peak in 
autophagosome formation and prior to significant macrophage 
infiltration from external sites.8 In contrast, in Becn1+/− or MEC-
specific Atg7-deficient mammary glands, dead cells abnormally 
accumulated at involution days 4 and 5, indicating that Atg-
deficient mammary tissues exhibited defective efferocytosis. It 
is of great interest that a recent study demonstrates the essen-
tial role of macrophages during the first phase of involution;49 
Atg defects compromise MEC phagocytic ability in vivo 
without impairing PS exposure or MFGE8 levels, but in asso-
ciation with decreased expression of apoptotic body receptors 
on phagocytes. The in vivo phagocytic ability of wild-type and 
Atg-defective MECs during involution was quantified and a sig-
nificantly decreased phagocytic index for Becn1+/− MECs was 
observed (Fig. 6A). Phagocytic index quantification by EM was 
performed only for Becn1+/− glands, as in this model all MECs 
were Becn1-heterozygous, whereas in the ATG7 model, despite 
the well-documented and efficient transgene deletion in the secre-
tory epithelial cells,35,36 individual MECs scored for phagocytic 
ability could be wild type and might have negatively impacted 
the accuracy of phagocytic index determination.
To elucidate the mechanism underlying the dead cell clear-
ance defect in Atg-deficient involuting mammary glands, we 
serially investigated the functionality of different efferocytosis 
players,41 starting with the apoptotic cells, which are known to 
‘actively’ participate in their own removal by exposing ‘eat-me’ 
receptors (PS) on their cell membranes, thus providing recog-
nition signals to neighboring phagocytes. Wild-type, Becn1+/− 
and MEC-specific Atg7-deficient involuting mammary glands 
showed similar PS exposure on dead cells (Fig. 6B), indicating 
that Atg-defective MECs give rise to “phagocytosis-competent” 
ABs in vivo.
Milk fat globule-EGF-factor 8 (MFGE8) is a glycoprotein at 
the apical plasma membrane of secretory MECs and on the milk 
fat globule membrane (MFGM) around secreted milk fat that 
acts as an opsonin and facilitates AB clearance; MFGE8 defi-
ciency results in dead cell accumulation during involution,42 sim-
ilar to that described above for Atg-deficient mammary glands 
(Fig. 5A, D and G). MFGE8 protein levels in wild-type and Atg-
deficient mammary tissues were similar (Fig. 6C), thus excluding 
altered MFGE8 expression as contributing to AB accumulation 
in Atg-defective mammary glands.
We next examined the expression of AB receptors on phago-
cytes, concentrating on those implicated in MEC-mediated 
efferocytosis,10,27,43 and found that MERTK and integrin β5 
(ITGB5) exhibited decreased levels in Atg-deficient mammary 
glands, whereas other receptors, such as CD14, which is upregu-
lated during involution and becomes exposed on the surface of 
MECs in a STAT3-dependent manner,10,19 and CD68 showed 
genotype-independent expression (Fig. 6D).
Persistence of inflammation and ductal ectasia in Atg-
defective mammary glands. Defective dead cell clearance com-
monly results in inflammation, as secondary necrosis and highly 
immunogenic intracellular antigen exposure occur in parallel 
with decreased anti-inflammatory cytokine secretion by phago-
cytes.44 To investigate whether dead cell accumulation in Atg-
defective mammary glands altered the inflammatory response 
normally associated with involution,27 macrophage infiltration 
was assessed (Fig. 7A and B). In wild-type glands, macrophages 
were clearly present until involution day 10, but depleted in fully 
involuted glands, whereas in Atg-deficient mammary tissues, 
macrophages persisted past involution completion (Fig. 7A and 
B), were of the alternatively activated M2 subtype45 (Fig. 7C, left 
column), and were accompanied by increased collagen deposition 
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Figure 6. Atg-deficiency impairs efferocytosis during mammary involution in association with decreased MeRTK and iTGB5 levels, but without com-
promising Ps exposure on apoptotic bodies or MFGe8 expression. (A) (Left panel) eM micrographs of Becn1+/+ and Becn1+/− mammary glands on day 2 
post-weaning. Red arrows point to autophagosomes (engulfed by Mecs in wild type, non-engulfed in Becn1+/− gland); (Right panel) Phagocytic index, 
i.e., fraction of engulfed over total number of autophagosomes in hPF. (B) Annexin V ihc on mammary glands from wild-type, Becn1+/− and Mec-specif-
ic Atg7-deficient mice on day 2 post-weaning. (C) MFGe8 ihc on mammary glands from wild-type, Becn1+/− and Mec-specific Atg7-deficient mice on day 
3 post-weaning. (D) MeRTK, iTGB5, cD14 and cD68 ihc on mammary glands from parous wild-type, Becn1+/− and Mec-specific Atg7-deficient mice at  
48 h post-weaning.
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Figure 7. For figure legend, see page 469.
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controlled by endocytic processing will be the subject of future 
studies. Elucidation of the nature of the engulfment defect in 
Atg-deficient MECs and its etiologic connection to decreased 
MERTK and ITGB5 expression will also be investigated.
Autophagy protein defects delay mammary involution. 
Autophagy induction was previously documented in involut-
ing bovine mammary glands,52 but our studies are the first to 
demonstrate the functional role of ATG proteins in mammary 
involution using transgenic mouse models. Participation of the 
autophagic machinery in involution process is not surprising 
given accumulating evidence for the critical role of autophagy 
in diverse developmental events,53 such as spore formation in 
yeast,54,55 dauer formation in C. elegans,56 oocyte-to-embryo57 
and embryo-to-neonate58-61 transitions in mammals. Autophagy 
induction during developmental tissue remodeling often accom-
panies apoptosis, as exemplified by germline P granule degrada-
tion in somatic cells in C. elegans62,63 and by salivary gland63 
and midgut64 degradation in Drosophila; furthermore, auto-
phagy is essential for midgut cell death even when apopto-
sis is inhibited.64 The latter studies implicate autophagy as an 
active PCD mechanism in Drosophila, which is a an intrigu-
ing finding given the more commonly observed cytoprotective 
roles of autophagy.65 In our studies, autophagy and apoptosis 
are induced in parallel during mammary involution and whole 
organ or MEC-specific Atg defects transiently delay mammary 
gland remodeling due to impaired dead cell clearance after the 
peak of autophagosome formation and without affecting apop-
totic rates. Thus, although autophagy as a process of self-eating 
is not essential for MEC death, ATG proteins are required for 
AB clearance and, thus, act as late PCD and heterophagy effec-
tors.66 In this respect, our studies shed light into the function 
of ATG proteins as mediators of efferocytosis which, though 
related to and sharing machinery with, is a process distinct from 
autophagy, as it does not involve self-cannibalism. Quite inter-
estingly, whole mounts of Atg-deficient involuting mammary 
glands (Fig. 4) show persistent mammary tissue compared with 
wild-type glands, macroscopically reminiscent of the develop-
mentally nondegraded atg-mutant Drosophila salivary glands.63 
Given the more recently reported requirement for the engulf-
ment receptor Draper in activation of autophagy regulators and 
degradation of Drosophila salivary glands67 and our results of 
impaired efferocytosis in Atg-deficient mammary glands in 
association with decreased MERTK and ITGB5 expression, it 
is conceivable that Drosophila salivary gland degradation and 
mammary involution may be very similar in their utilization 
of ATG proteins for efficient cell clearance during develop-
ment. Further investigation will provide critical insight into the 
similarities and differences between these two developmentally 
important PCD processes.
our results complement this study, as well as earlier work,8,43 in 
showing that both MECs and macrophages have critical con-
tributions to proper execution of this important developmental 
process.
Accelerated apoptosis cannot be ruled out as a reason behind 
dead cell accumulation in Atg-defective glands; however, the 
finding that Becn1+/− and Atg7-deficient MECs exhibit decreased 
dead cell engulfment even at 48 and 72 h post-weaning (Fig. 5C 
and F), when the total number of ABs is Atg-independent (Fig. 
5B and E), clearly indicates a defect in dead cell clearance in Atg-
deficient mammary glands.
An earlier study reports that Atg defects result in cell corpse 
persistence due to failed AB clearance during embryonic cavita-
tion.46 In that case, dying cells in Atg5- or Becn1-null embryoid 
bodies (EBs) fail to generate energy-dependent engulfment sig-
nals, such as the ‘eat-me’ (PS exposure) and the ‘come-get-me’ 
(LPC secretion) signals, and the efferocytosis defect is attrib-
uted to the production of ‘defective’ ABs by Atg-defective cells. 
However, in the afore-mentioned study, other mechanisms 
potentially impairing AB clearance were not investigated, leaving 
open the possibility of defects in other dead cell clearance effec-
tors, such as phagocytes.
Our results demonstrate proper PS exposure on Atg-deficient 
ABs in vivo (Fig. 6B) and in vitro (Fig. 8B) and, together with 
Atg-independent expression of the opsonin MFGE8 (Fig. 6C and 
D), indicate that defective phagocytes account for the efferocy-
tosis impairment. This finding is in close agreement with stud-
ies on dead cell34 and pathogen29 phagocytosis by macrophages, 
apoptotic corpse clearance during C. elegans development,32,33 
and the live-cell-engulfment process of entosis.32 The novel con-
tribution of our work is in reporting for the first time that Atg 
defects in MECs impair efferocytosis during mammary involu-
tion in vivo at the early step of engulfment. Our results are greatly 
supported by a completely independent study that has recently 
reported involvement of BECN1 in engulfment of apoptotic cells 
by macrophages and fibroblasts in vitro.50 Thus, inefficient effe-
rocytosis—and by extension, phagocytosis—likely involves more 
aspects of the phagocytic process than the previously documented 
endocytic processing. Although we did not investigate processing 
in Atg-deficient MECs, it is quite likely defective, given the emerg-
ing literature mentioned above. The combination of engulfment 
and processing defects in Atg-deficient MECs is very intriguing, 
especially in light of recent work indicating that engulfment 
depends on apoptotic material processing.51 In support of this 
hypothesis, we never detected Becn1+/− MECs “stuffed” with ABs; 
instead in all cases examined, multiple apoptotic corpses were 
near or on the phagocyte, but only one was ingested, as if engulf-
ment rate were strictly regulated. Whether the engulfment defect 
in Atg-deficient MECs is primary or secondary to a feedback loop 
Figure 7 (See opposite page). involution delay due to Atg-deficiency is accompanied by persistence of inflammation, M2-macrophage infiltration, 
increased collagen deposition and ductal ectasia. (A) F4/80 ihc on mammary glands from wild-type, Becn1+/− and Mec-specific Atg7-deficient mice on 
days 5–21 post-weaning. (B) Macrophage quantification in mammary glands from wild-type, Becn1+/− and Mec-specific Atg7-deficient mice on days 
5–21 post-weaning. (C) ARG1 ihc (left column); Mason trichrome staining (right column) on mammary glands from wild-type, Becn1+/− and Mec- 
specific Atg7-deficient mice on day 21 post-weaning. (D) Whole gland mount (left column) and h&e-stained sections (right column) of mammary 
glands from parous wild-type, Becn1+/− and Mec-specific Atg7-deficient mice.
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Figure 8. BecN1 or ATG7 knockdown in wild-type iMMecs compromises efferocytosis in vitro without affecting Ps exposure on apoptotic bodies, but 
in association with decreased engulfment-related RAc1 activation. (A) Phagocytic index for stable Becn1+/− and Becn1+/− iMMec lines in vitro.  
(B) Phagocytic index for wild-type iMMecs treated with scrambled or Atg (Becn1 or Atg7) siRNA. (C) Quantification of BecN1 and ATG7 knockdown in 
wild-type iMMecs. (D and E) FAcs-based quantification of Ps exposure on apoptotic bodies derived from wild-type iMMecs treated with scrambled 
or Atg (Becn1 or Atg7) siRNA. (F) efferocytosis-induced RAc1 activation in wild-type iMMecs treated with scrambled or Atg (Becn1 or Atg7) siRNA.
www.landesbioscience.com Autophagy 471
indicating that ATG protein defects may alter the tumor-mod-
ulating properties of the mammary microenvironment during 
involution and, thus, affect tumor progression risk. Atg-deficient 
mammary glands from retired breeders exhibit ductal ectasia, 
which, although not considered a preneoplastic change, is a mani-
festation of abnormal mammary gland remodeling. At this point, 
the etiologic origin of the ductal ectasia phenotype cannot be pre-
cisely defined, as more than one process can be contributing to 
it, including the intraductal persistence of ABs and its resultant 
proinflammatory response and/or the chronic inflammation due 
to defective autophagy-induced cell susceptibility to metabolic 
and tissue stressors. Along the same lines, not only inflammation 
may follow decreased AB clearance, but also defective autophagy-
associated inflammation may impair the phagocytic ability of 
MECs, leading to a self-sustaining proinflammatory microenvi-
ronment. Whether impaired efferocytosis and persistent inflam-
mation due to Atg deficiencies are mechanistically connected to 
lower BECN1 expression in human breast cancer71 remains to be 
investigated.
Materials and Methods
Mice and induction of involution. Becn1+/−,72 Atg7F/F;WAP-Cre73 
and Gfp-Lc374 mice were previously described.
PCR primers for genotyping were as following:
Becn1:
NeoESPCR2: 5'-CGC CTT CTA TCG CCT TCT TGA 
CG-3'
BCNKOT-1C: 5'-TGG AGG GCA GTC CAT ACC CTG-3'
BCNKOT-2R: 5'-GAG CTG GCT CCT GTG AGT ATG-3'
Atg7F:
Hind-Fw: 5'-TGG CTG CTA CTT CTG CAA TGA TGT-3'
Pst-Rv: 5'-CAG GAC AGA GAC CAT CAG CTC CAC-3'
Cre:
C001: 5'-ACC AGC CAG CTA TCA ACT CG-3'
C002: 5'-TTA CAT TGG TCC AGC CAC C-3'
Gfp-Lc3:
GFP(LC3)1: 5'-TCC TGC TGG AGT TCG TGA CCG-3'
LC3*rc3: 5'-TTG CGA ATT CTC AGC CGT CTT CAT 
CTC TCT CGC-3'
Mice were housed in a pathogen-free facility at the Child 
Health Institute of New Jersey. Animal protocols were IACUC-
approved. Atg7F/F;WAP-Cre mice were used after two pregnancy-
lactation cycles to ensure maximum CRE-recombination.35,36 
For involution studies, litter size was normalized to 6–8 pups. 
After 14 d of nursing,8,42,45 dams were separated from their pups. 
Thoracic and abdominal mammary glands were harvested at 
0–21 d time points after forced weaning, 3–5 mice per time 
point. Mammary glands were also harvested from nulliparous 
and multiparous mice at older ages.
qRT-PCR. Protein and RNA were isolated from nulliparous, 
lactating and involuting Becn1+/− and MEC-specific Atg7-deficient 
mammary glands using the PARIS kit (Applied Biosystems). 
Brilliant II SYBR Green 2-step QRT-PCR with AffinityScript 
Master Mix (Agilent) was used to convert 100 ng RNA to cDNA 
using a Veriti Thermal Cycler (Applied Biosystems). Relative 
Mammary epithelial cells as nonprofessional phagocytes. 
In the mammary gland, epithelial cell death followed by corpse 
clearance is a frequent event, first observed in puberty, when solid 
epithelial cords are canalized to form ductal outgrowths,68 and 
then recurring through the entire female reproductive life with 
each menstrual/estrous cycle, during which the mammary epi-
thelium proliferates moderately and either continues to do so if 
pregnancy occurs or undergoes apoptosis.69 The most extreme 
form of this cell proliferation-followed-by-cell death process hap-
pens during pregnancy, lactation and subsequent involution, at 
which time AB clearance is essential for proper stroma remodel-
ing and mammary gland regression to a “quiescent” state.1 It is 
of great interest that the cells responsible for dead body removal 
are living MECs acting as nonprofessional phagocytes.8,27 Recent 
work using mice deficient for different receptor tyrosine kinases 
that regulate efferocytosis in macrophages showed that MERTK, 
but not AXL or TYRO3, is critical for MEC-mediated efferocy-
tosis in the postpartum mammary gland,43 a finding that is in 
agreement with our observation that MERTK and ITGB5 expres-
sion was suppressed in Atg-deficient involuting mammary glands. 
Indeed the Mertk-null mice exhibited the same post-lactational 
involution phenotype as our Atg-deficient models: AB accumu-
lation and stagnant milk in alveolar lumens by involution day 
3, followed by eventual dead cell and debri clearance in associa-
tion with epithelial and stromal alterations. In the MERTK and 
BECN1 models, both MECs and macrophages were mertk−/− and 
Becn1+/−, respectively, raising the possibility that defective profes-
sional phagocytes were at least partially responsible for impaired 
efferocytosis. Transplantation of mertk−/− mammary epithelium 
into wild-type mammary fat pads resulted in a similar dead-cell-
accumulation phenotype, suggesting that MECs are the primary 
efferocytes during involution. Our ATG7 mammary model 
combines phagocytosis-defective (atg7−/−) MECs and wild-type 
stroma in the same transgenic mouse for the first time and, thus, 
proves beyond a doubt that MECs are the primary efferocytes 
during involution.
Involution-associated inflammation. Transient inflamma-
tion is an undisputable characteristic of mammary involution, as 
macrophages infiltrate the mammary gland by day 4 post-wean-
ing and orchestrate stroma remodeling. Increased immune medi-
ator expression during involution is consistent with an immune 
cascade resembling an early acute-phase response and a wound 
healing process.10,15,48 In breast cancer, macrophage infiltration 
and PABC are both associated with poor clinical outcomes, an 
observation that led to the involution-hypothesis stating that 
the wound healing microenvironment of the involuting mam-
mary gland is tumor-promotional and implicated in the high rate 
of associated distant metastasis.11,12 Examination of rodent and 
human mammary tissues revealed that involution macrophages 
and their associated stroma exhibit characteristics possibly driv-
ing breast cancer progression, such as an alternatively activated 
M2 phenotype, IL4 and IL13 proinflammatory cytokine pro-
duction, fibrillar collagen accumulation and high cyclooxygenase 
2 (PTGS2) expression.45,70 Our studies revealed that ineffective 
AB clearance due to Atg deficiencies result in inflammation that 
persists beyond full mammary gland regression (Fig. 7A–C), 
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anti-Arginase-1 (Santa Cruz, sc-18351), rabbit polyclonal anti-
MERTK (FabGenuix, MKT-121AP), rabbit polyclonal anti-
ITGB5 (Santa Cruz, sc-14010), rabbit polyclonal anti-CD14 
(Abcam, ab106285), rat monoclonal anti-CD68 (AbD Serotec, 
FA-11, MCA-1957GA), rabbit monoclonal anti-MFGE8 (kindly 
provided by Dr. Kamran Atabai, University of California, 
San Francisco). Sections were further incubated at RT for 1 h 
with the following biotinylated antibodies: goat polyclonal 
anti-rabbit (Novus, NB 730-B) or bovine anti-goat (Jackson 
ImmunoResearch, 711-065-152). Antibodies were diluted in 
5% goat serum, 5% BSA or M.O.M. diluent, depending on 
specific antibody source. Vectastain Elite ABC Reagent (Vector 
Laboratories, PK-7100) and DAB+ Substrate Chromogen Kit 
(Dako, K3468) were used to visualize biotin signal.
For collagen staining, deparaffinized and rehydrated sec-
tions were incubated overnight at RT in Bouin’s solution (Sigma, 
HT10132-1L) prior to Masson trichrome staining (Sigma 
Accustain Trichrome Kit HT15).
For phosphatidylserine (PS) detection in vivo, glands were 
incubated in Annexin-V-Biotin in Ca-binding buffer (TACS 
Annexin V-Biotin kit, Trevigen 4835-01-K) according to the 
manufacturer’s instructions prior to fixation with 4% PFA, par-
affin-embedding and sectioning. Dewaxed and rehydrated sec-
tions were incubated with 3% peroxide, rinsed and blocked with 
5% goat serum, incubated at 4°C overnight with Vectastain Elite 
ABC Reagent, rinsed with 0.5% Tween-20 in PBS and developed 
in DAB+ Substrate.
For all staining described above, sections were mounted with 
Permount medium (Fisher, SP15-100).
Electron microscopy. 1-mm3 specimens were excised from 
3 randomly selected areas of abdominal mammary glands, 
fixed in 2.5% glutaraldehyde, 4% PFA, 8 mM CaCl
2
 in 0.1 M 
cacodylate buffer pH 7.4, and processed for conventional elec-
tron microscopy at UMDNJ Electron Microscopy Core facility 
(JEOL 1200EX electron microscope).
Phosphatidylserine analysis in vitro. Wild-type iMMECS 
transfected with scrambled, Becn1 or Atg7 siRNAs were grown in 
6-well plates in regular growth medium for 48 h, then in serum/
glucose-free DMEM to initiate apoptosis. Apoptotic cells were 
harvested 14 h later and stained (unfixed) with FACS Annexin 
V-FITC kit (Trevigen, 4830-01-K). FITC/PI cell ratio was 
determined within 1 h using Beckman-Coulter Cytomics FC500 
Flow Cytometer. To visualize PS exposure, cells were grown on 
coverslips, starved overnight, stained with Annexin V-FITC/PI, 
and mounted with ProLong Gold antifade medium.
Macrophage quantification. Macrophage infiltration was 
quantified by using the measurement option of the ProgRes 
CapturePro 2.5 camera software. Basically, F4/80-stained areas 
for macrophages and hematoxylin-stained areas for mammary 
tissues were measured on paraffin-embedded specimen sections 
(images taken at 400x magnification). Ten fields/section and one 
section from 3 different mice per genotype per involution time 
point were analyzed. Results are presented as macrophage (F4/80 
staining) to tissue (hematoxylin staining) ratios.
Phagocytosis assays. FACS-based assay: iMMECs trans-
fected with scrambled, Becn1 or Atg7 siRNA recovered for 
mRNA expression was analyzed on a Stratagene MX3005P 
(Agilent), normalized to a housekeeping gene (Acta1) and com-
pared with mRNA from virgin mammary glands using the ΔΔCt 
method performed by the Comparative module on the MxPro 
software (Agilent).
Primers (Integrated DNA Technologies) used were as fol-
lowing: Acta1 Forward: 5'-GGT ATC GCT GAC CGC ATG 
CAG A-3', Reverse: 5'-CCT GAG GAG AGA GAG CGC GAA 
CG-3'; Becn1 Forward: 5'-CTC AAG TGG GGT CTT GCC 
TGG GT-3' Reverse: 5'-GAA AGG ATG CAT GGG GCT GAG 
TC-3'; Map1lc3α Forward: 5'-TAA TCA GAC GGC GCT TGC 
AGC T-3' Reverse: 5'-TGT GGG TGG TGA GCC GTC CA-3'
Cell culture. Becn1+/+ and Becn1+/− mouse mammary epithe-
lial cells (MMECs) were isolated and immortalized (iMMECs) 
as previously described.39 Wild-type iMMECs were electropor-
ated with scrambled, Becn1 or Atg7 mouse siRNAs (Thermo 
Scientific, D-001050-01-20; M-055895-01-0005; M-049953-
02-0020) for ATG regulator knockdown in vitro.
Cells were seeded on 100-mm plastic dishes, 6-well plates, 
coverslips or chamber slides depending on specific experiment 
and grown in F12 medium supplemented with 10% FBS, 5 μg/
ml insulin, 1 μg/ml hydrocortisone, 5 ng/ml EGF, 100 U/ml 
penicillin and streptomycin at 37°C in a humidified atmosphere 
containing 5% CO
2
. To induce apoptosis, cells were incubated 
in glucose/serum-free Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with hormones and antibiotics for 14 h.
Mammary gland processing and analysis. Whole mount: 
Freshly dissected abdominal mammary glands were spread 
between glass slides and fixed in 4% paraformaldehyde (PFA) 
at room temperature (RT) for 2 h. After acetone defatting and 
alcohol rehydration, tissues were stained overnight in carmine 
alum solution (Carmine, Sigma C-1022; aluminum potassium 
sulfate, Sigma A-7167) followed by dehydration and clearing in 
xylene.
For H&E and IHC, glands were fixed in 4% PFA, embed-
ded in paraffin and sectioned. H&E staining followed by digi-
tal scanning was performed at the Mouse Pathology Laboratory, 
University of California, Davis.
For frozen sections, tissues were incubated in sucrose gradient 
prior to processing. Sections were fixed in acetone and mounted 
with ProLong Gold antifade reagent (Invitrogen, P36930). 
EGFP-LC3 fluorescence was monitored by epifluorescence 
microscopy.
For IHC, sections were deparaffinized in xylene, rehydrated 
with alcohol and blocked with 3% peroxide, followed by 1 h incu-
bation with 5% goat serum or 5% BSA, depending on primary 
antibody source. Vector M.O.M. Immunodetection kit (Vector 
Laboratories, BMK-2202) was used for rat primary antibody.
Tissue sections were incubated at RT for 1 h or at 4°C over-
night with the following primary antibodies: rabbit polyclonal 
anti-ATG7 (Sigma, A2856), rabbit polyclonal anti-BECN1 
(Santa Cruz, sc-11427), rabbit polyclonal anti-LC3 (Novus, 
NB100-2331), rabbit polyclonal anti-cleaved caspase-3 (Cell 
Signaling, 9661), rat monoclonal anti-F4/80 (AbD Serotec, 
A3-1, MCA497), rabbit polyclonal anti-iNOS/NOS Type 
II (BD Transduction Laboratories, 610333), goat polyclonal 
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on autophagy status. Coverslips were stained for actin with 
Rhodamine Phalloidin (Cytoskeleton, PHDR1).
Statistical analysis. Student’s t-test was used for statistical 
analysis.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
I.T., F.L., S.S., B.R. and V.K. designed and analyzed experiments; 
I.T., F.L., S.S and S.P. performed experiments; N.B. and R.D.C. 
reviewed mouse mammary gland histology; V.K. supervised 
project; V.K. wrote manuscript; all authors reviewed manuscript.
We thank N. Mizushima (Tokyo Medical and Dental University; 
Gfp-Lc3 mice), Z. Yue and S. Jin (Mount Sinai School of Medicine 
and University of Medicine and Dentistry of New Jersey; Becn1 
mice), M. Komatsu (Tokyo Metropolitan Institute of Medical 
Science; Atg7F/F mice), K. Atabai (University of California, San 
Francisco; MFGF-8 antibody). We also thank R. Patel for assis-
tance with electron microscopy, N. Goldsmith-Kane for assistance 
with confocal microscopy, K. Bell at the Center for Comparative 
Medicine, University of California at Davis for assistance with 
mammary tissue processing and fixation, the Cancer Institute of 
New Jersey Tissue Analytical Services and the Flow Cytometry 
and Immunology Core Laboratory at University of Medicine and 
Dentistry of New Jersey-New Jersey Medical School. We are grate-
ful for financial support from a New Jersey Commission on Cancer 
Research Predoctoral Fellowship (F.L.), NIH grant R00 (V.K.) 
and a Damon Runyon Clinical Investigator Award (V.K.).
48 h post-transfection. Wild-type iMMECs labeled with red flu-
orescent cell linker PKH26 (Sigma, MINI26) were maintained 
in glucose/serum-free DMEM for 36 h for apoptosis induction. 
Cell death was verified by Annexin V-FITC/PI staining. PKH26-
labeled apoptotic cells were added in 1:10 ratio to siRNA-trans-
fected cells growing in regular growth medium and co-cultured 
for 14 h. Phagocyte monolayer was washed with PBS to remove 
bound, nonengulfed, apoptotic cells, stained with CellTracker 
Green BODIPY dye (Invitrogen, C2102), harvested by tryp-
sinization and fixed with 1% PFA for 20 min on ice. Samples 
were acquired on an Amnis Imagestream 100 and analyzed by 
IDEAS 4.0 software. Internalization was determined by first gat-
ing for nuclear stain (Draq5) to identify intact cells. These were 
then analyzed for BODIPY Green-positive cells (phagocytes) by 
gating for Intensity BODIPY Green. Single cells were selected 
to remove large aggregates and doublets and then analyzed for 
percent PKH26-positive cells by gating for Intensity PKH26 
vs. Area Draq5 to exclude conjugates and aggregates. PKH26-
positive events were gated off of BODIPY Green cells alone as a 
control.
RAC1 activation assay. Cells were grown and siRNA trans-
fections were performed as described above. Wild-type apoptotic 
cells were added in 1:10 ratio; phagocytosis was terminated by 
ice-cold PBS wash. Phagocyte monolayer was washed with PBS 
to remove bound, nonengulfed apoptotic cells and harvested by 
scraping at 0, 0.5 and 5 h time points after apoptotic cell addi-
tion. Assay was performed with G-LISA RAC Activation Assay 
Biochem (absorbance-based kit, Cytoskeleton BK125) accord-
ing to manufacturer’s manual, except that cells were grown in 
serum-containing medium to avoid starvation-induced effect 
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